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Abstract: Effects of different concentrations of monensin on contraction amplitude (CA) which is the contraction force (CF), initial
contraction velocity (ICV), average contraction velocity (ACV) and initial relaxation velocity (IRV) of guinea-pig papillary muscle were
studied by using male guinea-pigs. Hearts were removed and papillary muscles were isolated from the right ventricles. The muscles
were then attached to a capacitance transducer, electrically connected to a Beckman recorder and the isometric contractions of
guinea-pig papillary muscles were recorded. The five hours of measurement in this experiment were divided into five periods (T0
was equilibration, T1, T2, T3 and T4 were respectively one, two, three and four hours after drug administration). Two µmol/l
monensin did not change any parameters at any time period. Although 12 µmol/l monensin did not change the CA, ACV or IRV at
any time period, it increased the ICV at T2. Seven µmol/l monensin, on the other hand, increased the CA and IRV at T2, T3 and T4
and the ICV and ACV at T1, T2, T3 and T4. It is concluded that the effect of monensin in guinea-pig papillary muscles is dose
dependent. It is also concluded that although the therapeutic range of monensin is very narrow, it should be considered as an alternative drug for the treatment of congestive heart failure (CHF). However, more studies are needed to domenstrate the effectiveness of monensin on the tratment of congestive heart failure.
Key Words: Monensin, papillary muscle, calcium, positive inotrope, guinea-pig

Monensinin Farklı Dozlarının Kobay Papillar Kas Kontraktilitesi Üzerindeki Etkileri
Özet : Monensinin farklı dozlarının popillar kas kasılma gücü (KG), başlangıç ve ortalama kasılma hızı (BKH ve OKH) ve başlangıç
gevşeme hızı (BGH) üzerindeki etkileri erkek kobaylar kullanılarak çalışıldı. Kalp vucuttan uzaklaştırıldıktan sonra papillar kaslar sağ
ventrikulusdan izole edildi. İzole edilen kaslar elektriksel olarak bir poligrafa bağımlı transdüsere bağlandıktan sonra izometrik
kasılmalar ölçüldü. Ölçümler beş değişik zaman diliminde yapıldı (T0 denge ve T1, T2, T3, T4 ise sırasıyla ilaç uygulamasından 1, 2,
3 ve 4 saat sonrasını ifade etti). İki µmol/l monensin herhangi bir parametrede, hiçbir zaman diliminde istatistiksel olarak önemli bir
değişiklik oluşturmazken, 12 µmol/l monensin sadece BKH’ı T2'de artırdı. Buna karşılık 7 µmol/l monensin KG ve BGH’ı T2, T3 ve
T4'de ve BKH ve OKH’ı T1, T2, T3 ve T4'de artırdı. Bu sonuçlar monensinin kobay papillar kaslar üzerindeki etkisinin doza bağımlı
olduğunu ortaya koydu. Monensinin terepatik oranı oldukça dar sınırlar içerisinde olmasına rağmen, kalp yetmezliğinin tedavisinde
kullanılmak üzere alternatif bir ilaç olarak üzerinde çalışılması gerektiği sonucuna varıldı. Ancak monensinin kalp yetmezliğinin
tedavisinde etkili bir şekilde kullanılabileceğini kanıtlamak için daha fazla çalışmaya ihtiyaç vardır.
Anahtar Sözcükler: Monensin, papillar kas, kalsiyum, pozitif inotrop, kobay

Introduction
Ionophores carry ions across lipid barriers as complexes soluble in the lipid phase of membranes. The
potential use of ionophores as probes of biological
function, or as potential therapeutic agents, was recognized very early, but major economic importance
was not forthcoming until the discovery of monensin
in 1967 (1).
Initially, Shumard and Callender, 1969 (2) recognized the effectiveness of monensin against experimental infections of coccidoia in chickens and subsequently
it was used widely in birds for control of coccidiosis.

Monensin is also efficacious in the control of coccidiosis in lambs and calves (3, 4). In beef cattle, it
improves the feed efficiency by 10-15% due to an
increase in the production of more propionic acid
which yields more energy than acetic or butyric acids
following ruminant fermentation (5).
Of the more than one hundred ionophores that
have been reported, three, monensin, lasalocid, and
salinomycin, have wide spread commercial use and of
these, licenced monensin is probably used most widely
(1). Among the domestic animals, horses are most
sensitive to monensin toxicity (6). If monensin is used
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as a coccidiostat or growth promoter in other species,
the drug-treated feed would be dangerous if accidentally consumed.
Monensin has also a strong positive inotropic effect
in cardiac muscle (7, 8, 9). This effect occurs because,
as an ionophore, monensin has strong affinity for
[Na+]0. The affinity of monensin for Na+ is ten times
that for K+, its nearest competitor in biological systems (1). The monensin-induced increase in [Na+]l
facilitates the entry of Ca2+ into the cell by a Na+
(out) / Ca2+ (in) exchange mechanism (10). This Ca2+
shift is the primary factor mediating the cellular
response. Another factor modifying the cellular
response includes the alteration of the pH of intracellular components (pHl) since monensin increases the
pHl by transferring H+ out of the cell (1).
In the present study, effects of different concentrations of monensin on contraction amplitude (CA) which
is the contraction force (CF), inital contraction velocity
(ICV), average contraction velocity (ACV) and initial
relaxation velocity (IRV) of guinea-pig papillary muscle
were investigated over a four-hour experimental
period. Many pharmacological experiments have compared different drugs according to their initial effects.
Treatment of papillary muscles with monensin for four
hours gave us a better understanding of the effect of
monensin with time.
The purpose of the present study was to evaluate
the inotropic effect of monensin in guinea-pig papillary
muscle by using different concentrations of monensin
and to investigate whether this effect of monensin
would change in time. The objective of this experiment
was to establish the need for further investigation of
monensin for the possibility of using it in the management of certain clinical syndromes such as congstive
heart failure (CHF).
Materials and Methods
Preparation of papillary muscles:
Male guinea-pigs, 500-600 g, were heparinized
(1000 IU per animal, IP injection) 30 minutes before
being decapitated. One animal was used per day.
Hearts were removed rapidly and put in a beaker
filled with ice-cold KRB of the following composition
[mmol/1]: Na+, 115.9: Ca2+, 2.2: K++, 4.0: Mg2+, 1.3:
Cl–, 126.9: H2PO4-, 2.1: HCO3-, 2.17: glucose, 10.9.
The pericardium was removed, and the aorta and the
pulmonary artery were excised. The hearts were transferred to a second beaker of the same solution, and
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then rapidly put in a glass pan filled with Krebs solution and bubled with 100% O2. Two papillary muscles
with diameters of approximately 1.0-1.5 mm were
dissected from the right ventricle of each guinea-pig
and each muscle was mounted in an organ bath containing a Krebs solution with 2.2 mmol/l CaCl2. The
Kreb solution was perfused with a mixture of 95% O2
and 5% CO2 and maintained at 37˚C. The pH was
maintained between 7.50-7.60. The muscles were
attached to a capacitance transducer (Harvard isometric capacitance transducer, Harvard apparatus, inc.,
South Notick, MA) electrically connected to a Beckman
recorder (R611). The tendon end of each muscle was
attached to the transducer by a silk suture and the
opposite end was held by a plastic clamp placed in the
muscle chamber. Muscles were stimulated at a frequency of 0.2 PPS by using a pair of platinum field
effect electrodes. The transducers to measure force
were calibrated for each experiment by using weights
(1 g equaled a displacement of 40 mm). Frequency
was calibrated by an oscilloscope.
Stock solutions:
Stock solutions of 1, 3.5 and 6 mmol/l monensin
(Sigma Chemical Co., St. Louis, MO) prepared with
alcohol were used. Four treatments were used; control
(0.18% alcohol), and monensin at 2, 7 and 12 µmol/l.
Each treatment was replicated four times. Treatments
were administered after an equilibration period of 35
min.
Contractility Experiment:
Sixteen papillary muscles were obtained from 8
guinea-pigs as described in the preceding section. Two
different treatments were used on the same day on
two different papillary muscles obtained from one
guinea pig. Data were obtained from each muscle five
times (before treatment application and 1, 2, 3 and 4
hours after continuos treatment). Variables measured
at each period included contraction amplitude, contraction angle, relaxation angle and stimulus to response
time. Contraction force (CF), initial contraction velocity
(ICV), average contraction velocity (ACV) and initial
relaxation velocity (IRV) were calculated as functions
of the measured variables.
Treatment design, experimental design and statistical analysis:
Four treatments were used in this study. Because
of the large variability among animals, a balanced
incomplete block design was selected as the experimental design. Each animal provided two muscles,
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individual muscles were the experimental unit for the
experiment. Blocks were size of two; with each block
containing two muscles from the same animal. Experimental units (a single muscle) were randomly allocated
to treatments. Analyses of variance were obtained
using SAS (SAS intitute, Inc., 1988, release 6.03,
Cary, NC). Unbiased estimates of treatment means and
their errors were obtained using the LSMEANs statement. The ANOVA indicated a significance when
P≤0.05. Contrasts (11) were used to test differences
among means.

Effects of different concentrations of monensin on
the CA, ICV, ACV and IRV of guinea-pig papillary muscle are presented in table 1, 2, 3 and 4, respectively.
Two µmol/l monensin did not change any parameters
at any time period (Table 1, 2, 3 and 4). Although
12 µmol/l monensin did not change the CA, ACV or
IRV at any time period (Table 1, 3 and 4), it
increased the ICV at T2 (Table 2). Seven µmol/l
monensin, on the other hand, increased the CA and

Effects of different concentrations of monensin on the
contraction amplitude (mm) of guinea-pig papillary
muscle. Mean ± standard error is shown (n=4). M.
monensin.

Time (hour)

Control

M-2

M-7

M-12

0
1
2
3
4

12.6±2.7
14.5±3.9
12.1±4.1
11.2±3.9
10.8±3.5

13.5±1.4
15.8±2.2
14.3±2.9
12.8±2.7
12.6±3.2

1.28±1.6
23.5±5.6
27.4±4.4*
25.6±3.2*
21.3±2.8*

14.2±1.9
21.1±4.8
19.2±6.8
13.8±4.4
11.6±4.9

*

denotes a significant difference between treatment and control
group (P≤0.05).

Table 2.

Effects of different concentrations of monensin on the
initial contraction velocity (g/sec) of guinea-pig papillary
muscle. Mean ± standard error is shown (n=4). M,
monensin.

Time (hour)

Control

M-2

M-7

M-12

0
1
2
3
4

1.14±0.2
1.34±0.3
1.31±0.3
1.61±0.4
1.49±0.3

13.4±0.3
1.45±0.2
1.56±0.2
1.56±0.2
1.55±0.2

1.34±0.1
3.07±0.4*
4.63±0.7*
4.17±0.5*
3.79±0.4*

1.60±0.5
2.62±0.6*
2.82±1.0
3.40±1.5
2.38±0.6

*

denotes a significant difference between treatment and control
group (P≤0.05).

Effects of different concentrations of monensin on the
average contraction velocity (g/sec) of guinea-pig papillary
muscle. Mean ± standard error is shown (n=4). M,
monensin.

Time (hour)

Control

M-2

M-7

M-12

0
1
2
3
4

0.88±0.2
1.18±0.3
1.09±0.3
1.45±0.3
1.38±0.3

0.89±0.2
1.13±0.1
1.15±0.2
1.06±0.2
1.03±0.2

0.98±0.1
2.66±0.6*
3.67±0.4*
4.10±0.8*
3.87±0.5*

1.17±0.4
2.79±1.3
2.57±1.0
2.51±0.9
2.00±0.6

*

Results

Table 1.

Table 3.

denotes a significant difference between treatment and control
group (P≤0.05).

Table 4.

Effects of different concentrations of monensin on the
initial relaxation velocity (g/sec) of guinea-pig papillary
muscle. Mean ± standard error is shown (n=4). M,
monensin.

Time (hour)

Control

M-2

M-7

M-12

0
1
2
3
4

0.63±0.1
0.91±0.2
0.86±0.3
0.96±0.4
1.10±0.2

0.61±0.2
0.75±0.2
0.97±0.2
0.94±0.2
0.93±0.2

0.66±0.1
1.78±0.5
3.30±0.5*
2.54±0.5*
2.63±0.3*

0.68±0.2
1.59±0.6
1.43±0.4
1.08±0.4
0.87±0.4

*

denotes a significant difference between treatment and control
group (P≤0.05).

IRV at T2, T3 and T4 (Table 1 and 4) and the ICV
and ACV at T1, T2, T3 and T4 (Table 2 and 3).
Discussion
This study was undertaken to evaluate the inotropic and toxic effects of the different concentrations
of monensin in guinea-pig papillary muscle and to
investigate whether these effects of monensin would
change in time. Contractility is the performance of a
heart at a given preload and afterload (18). An
increase in contractility (positive inotropic effect) is not
only reflected by increments in developed force but
also reflected by increments in velocity (18).
In this experiment it was found that 2 µmol/l
monensin did not change any parameter at any time
period. Although 12 µmol/l monensin did not change
the CA, ACV or IRV at any time period, it increased
the ICV at T2 (Table 2). Seven µmol/l monensin, on
the other hand, increased the CA and IRV at T2, T3
and T4 (Table 1 and 4) and the ICV and ACV at T1,
T2, T3 and T4 (Table 2 and 3). These results indi-
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cated that the effect of monensin on the contractility
of guinea-pig papillary muscles is dose dependent.
The 7 µmol/l monensin administration increased the
CA of guinea-pig papillary muscles at T2(120 min
after the treatment) and did not lose its positive inotropic effect with the elapse of time (Table 1). The
action of monensin rely on an increase in [Ca2+]i due
to an increased [Na+]i. Monensin binds Na+ outside of
the cell and carries it into the cell and increases [Na+]i
and thus [Ca2+]i (1). Although a Ca2+ shift is the primary factor mediating the cellular response of monensin, another factor modifying the cellular response is
the pHl change. Classically an acidosis reduces contractions by inhibiting the Na+-Ca2+ exchange (12, 13),
whereas an alkalosis increases contractions by stimulating Na+-Ca2+ exchange and the release of Ca2+ from
the sarcoplasmic reticulum (SR) (14). Monensin
increases the pHi due to the increased exit of a H+
when monensin is transported out of the cell causing
an increase in the CA (1).
To be able to demonstrate whether monensininduced increase in [Ca2+]i is due to an influx or a
release from the SR, we measured the ICV and the
ACV. There are two components, early (P1) and the
late (P2) components, of guinea-pig papillary muscle
contraction wave (15). The P1 is suggested to be generated by Ca+2 released from SR whereas P2 is
thought to be result from Ca+2 influx (15). The ICV
would be affected by the change in P1 and the ACV
would be affected by those factors that produce both
P1 nd P2 of the contraction wave (16). An increase in
the rate of Ca2+ release from the SR would increase
the ICV. The positive inotropic effect of monensin is
thought to be mediated by an increase in activator
Ca2+ which enters the cell and causes the release of
Ca2+ from the SR. Seven µmol/l monensin increased
the ICV and the ACV of guinea pig papillary muscles

at T1 and did not lose its effect with the elapse of
time (Table 2 and 3). This result indicated that
monensin might increase the rate of Ca2+ release from
the SR in guinea pig papillary muscles. However, more
studies are needed.
The IRV is affected by two mechanisms. First, a
SR Ca2+ -ATPase that pumps Ca2+ into the SR thus
decreases [Ca2+]i. Second, a Na+(in)/Ca2+ (out) exchange
(17). Under steady-state conditions, the amount of
Ca2+ entering the cell equals that which exits the cell,
and the amount released by the SR equals that
sequestered by the SR (17). If an abrupt change in
this balance of fluxes takes place, then the Ca2+ content of the SR will be affected. Seven µmol/l monensin
increased the IRV of guinea-pig papillary muscles at
T2 (Table 4). This increase in IRV was due to the SR
Ca2+-ATPase and the Na+(in)/Ca2+ (out) exchange which
would be stimulated when [Ca2+]i increased in order to
lower the increased [Ca2+]i.
It is concluded that although the therapeutic range
of monensin is very narrow, it should be considered
as an alternative drug for the treatment of congestive
heart failure (CHF). It is also concluded that increased
contraction velocity, as compard the control, is important; as an increased contraction velocity acts as an
decreased afterload to a functional heart and can be
an important contributor to heart failure. However,
more studies are needed to demonstrate the effectiveness of monensin on the treatment of congestive heart
failure.
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